ASCLETIS-B (01672) exercised the purchase of rights to subscribe for 254,000 shares.
GeLi Pharmaceutical-B (01672) announced that on April 24, 2025, a total of shares were issued due to the exercise of purchase rights...
ASCLETIS-B (01672) announced that on April 24, 2025, a total of 254,000 shares were issued due to the exercise of stock purchase rights.
Related Articles
US Stock Market Move | Federal Reserve officials blow "interest rate cut wind" three major indices rise
Giant Network Group (002558.SZ) 2024 Annual Report: Net profit increased by 31.15% year-on-year, AI innovation has been very effective.
US Stock Market Move | Trump will sign an executive order to promote the development of deep-sea mining. Odyssey Marine Exploration, Inc. (OMEX.US) surged over 90% at one point.
US Stock Market Move | Federal Reserve officials blow "interest rate cut wind" three major indices rise
Giant Network Group (002558.SZ) 2024 Annual Report: Net profit increased by 31.15% year-on-year, AI innovation has been very effective.
US Stock Market Move | Trump will sign an executive order to promote the development of deep-sea mining. Odyssey Marine Exploration, Inc. (OMEX.US) surged over 90% at one point.
RECOMMEND
Federal Reserve's Harker: Fed may cut interest rates in June if economic data is clear
24/04/2025
The big stick of tariffs cannot suppress the wave of AI-driven technology replacement. Is Apple Inc. entering a climax of stock price rebound with the "fruit chain"?
24/04/2025
Pan Gongsheng: There are no winners in a trade war or tariff war. China will continue to adhere to its policy of opening up to the outside world.
24/04/2025
